Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1238 |
|
Actual shortage: | 52 (4%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 36 (3%) | |
Resolved: | 1150 (93%) | |
Discontinuation Reports |
284 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 283 (100%) | |
Reversed: | 1 (0%) | |
Late reports |
205 (13%) |
|
Overdue reports |
5 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-05 | 2020-10-26 | 88585 |
PMS-CIPROFLOXACIN | 250MG | TABLET | Resolved | 2019-07-31 | 2020-03-10 | 90458 |
PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2019-07-31 | 2020-05-19 | 90464 |
PMS-LETROZOLE | 2.5MG | TABLET | Resolved | 2019-07-31 | 2020-05-19 | 90470 |
PMS-LOSARTAN-HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-07-31 | 2020-05-19 | 90473 |
PMS-MELOXICAM | 15MG | TABLET | Resolved | 2019-07-31 | 2019-11-15 | 90476 |
PMS-SUMATRIPTAN | 100MG | TABLET | Resolved | 2019-07-31 | 2020-06-10 | 90488 |
PMS-SUMATRIPTAN | 100MG | TABLET | Resolved | 2019-07-31 | 2019-09-12 | 90491 |
PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-08-01 | 2020-05-19 | 90536 |
PMS-DIGOXIN | 0.125MG | TABLET | Resolved | 2019-08-01 | 2019-10-03 | 90588 |
ATORVASTATIN | 80MG | TABLET | Resolved | 2019-09-12 | 2020-07-23 | 93810 |
PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-09-12 | 2020-05-19 | 93816 |
PMS-LOSARTAN-HCTZ | 25MG 100MG | TABLET | Resolved | 2019-09-12 | 2020-02-04 | 93819 |
PMS-METOPROLOL-L | 50MG | TABLET | Resolved | 2019-09-12 | 2019-11-04 | 93822 |
PMS-TETRABENAZINE | 25MG | TABLET | Resolved | 2019-09-12 | 2019-11-01 | 93840 |
PMS-AZITHROMYCIN | 250MG | TABLET | Resolved | 2019-09-18 | 2019-11-15 | 94260 |
PMS-OLANZAPINE | 2.5MG | TABLET | Resolved | 2019-09-18 | 2019-11-19 | 94272 |
PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-10-04 | 2022-01-17 | 95445 |
PHARMA-AMLODIPINE | 10MG | TABLET | Resolved | 2019-11-15 | 2020-05-19 | 98781 |
PMS-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2019-11-15 | 2020-03-10 | 98784 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Discontinued | 2020-04-09 | 2020-04-10 | 111618 |
CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Discontinued | 2020-06-16 | 2020-06-16 | 118017 |
PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Discontinued | 2021-03-11 | 2021-03-11 | 135474 |
PMS-CHLORAL HYDRATE SYRUP 100MG/ML | 100MG | SYRUP | Discontinued | 2018-08-24 | 2018-08-25 | 59103 |
PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2020-06-15 | 2021-10-27 | 117714 |
PMS-DOCUSATE SODIUM | 250MG | SYRUP | Discontinued | 2020-06-15 | 2021-10-27 | 117730 |
SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2021-06-21 | 2021-06-21 | 141302 |
PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2021-11-16 | 2021-11-16 | 149365 |
PMS-CHLORAL HYDRATE SYRUP 100MG/ML | 500MG | SYRUP | Discontinued | 2021-11-16 | 2021-11-16 | 149409 |
PMS-PAROXETINE | 10MG | TABLET TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117781 |
AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4990 |
AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4993 |
PMS-BISOPROLOL | 5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4999 |
PMS-DIAZEPAM | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 5002 |
AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
PMS-ENALAPRIL | 16MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6041 |
PMS-ENALAPRIL | 4MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6044 |
PMS-ENALAPRIL | 4MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6047 |